Sex steroids, including testosterone, regulate the development and function of the male skeleton. Oury et al. (2011) identify a surprising new connection between the skeleton and the testis, which has implications for male fertility. They show that testosterone production in the testis is directly influenced by the bone-derived hormone osteocalcin.
The sex steroids testosterone and estrogen are essential regulators of fertility. Acting through nuclear hormone receptors expressed in somatic cells, testosterone regulates the development and maintenance of the male reproductive system and, by modulating the activity of support cells, promotes germ cell survival. Testosterone synthesis occurs within Leydig cells in the testes and is regulated by luteinizing hormone (LH) produced by the pituitary gland. In addition to LH and follicle-stimulating hormone (which is also secreted from the pituitary), there is emerging evidence that metabolic hormones such as leptin (Tena-Sempere and Barreiro, 2002) and insulin (Ma and Wittert, 2010) have impacts on testis function. Now, Oury et al. (2011) demonstrate that the skeleton may play a previously unforeseen role in control of male fertility, showing that osteocalcin (Ocn), a peptide hormone that is secreted by bone-forming osteoblast cells, directly controls testosterone production by Leydig cells in the testis (Figure 1 ). Using ex vivo cell assays, the authors demonstrate that a factor that is secreted by osteoblasts, but not other skeletal cell-types, markedly increases testosterone production both by testis explants and by isolated Leydig cells. Speculating that this effect is likely to be mediated by osteocalcin, the authors show that this response is lost when Ocndeficient osteoblasts are used but is rescued in a dose-dependent manner by introduction of exogenous osteocalcin. Injection of osteocalcin also increases serum testosterone in mice. Together, these data strongly suggest that osteocalcin is indeed one of the osteoblast-secreted factors that are responsible for enhanced testosterone production.
To support their in vitro data, the authors exploit two mouse models in which osteocalcin function is either ablated (Ocn knockout mice) or enhanced (Esp knockout mice, which lack an osteotesticular phosphatase that negatively regulates osteocalcin maturation). Compared to controls, testis weight, sperm counts, and levels of circulating testosterone are all significantly reduced in Ocn knockout mice and conversely increased in Esp knockout males. Consistent with these physiological changes, Ocn-deficient males sire fewer offspring than controls, although no significant increase is observed using Esp-deficient males, possibly because the availability of oocytes acts as a limiting factor. Tissuespecific ablation of these genes in bone or testis confirms that osteocalcin derived from the skeleton acts as an endocrine factor to regulate male fertility.
How does osteocalcin influence testosterone synthesis? To identify the receptor through which osteocalcin signals, the authors postulate that, because the hormone stimulates cyclic adenosine monophosphate (cAMP) production in Leydig cells, it is most likely a G protein-coupled receptor (GPCR). By performing a comprehensive analysis of the expression pattern of 103 GPCRs, they identify four that are enriched in Leydig cells. Notably, a previous study reported that deletion of one of these, Gprc6a, results in a testicular phenotype, with increased circulating levels of estradiol and reduced levels of testosterone (Pi et al., 2008) . Oury and colleagues now demonstrate that Leydig cell-specific impairment of Gprc6a expression generates mice with an identical phenotype to Ocn-deficient animals. Their experiments suggest that osteocalcin signals through Gprc6a to regulate cAMP and the transcription factor CREB, which in turn promotes the expression of key steroidogenic enzymes.
One outstanding question that remains to be addressed is the relationship between LH-and osteocalcin-dependent signaling in regulation of Leydig cell function. Both of these hormones exert endocrine control over testosterone production, and although they act through different GPCRs, both are coupled to activation of cAMP-dependent signaling cascades. In this study however, even though animals lacking Ocn have significantly increased levels of serum LH, the increase in LH is apparently insufficient to compensate for loss of function of the osteocalcin pathway. This suggests that LH and osteocalcin may act through different effector molecules. It would therefore be interesting to establish whether exogenous osteocalcin could rescue the phenotype of LH-beta knockout mice (Zhang et al., 2001 ).
Androgens such as testosterone not only regulate testis function, but also play a key role in the function of the rest of the male urogenital system. Oury et al. show that mice in which Leydig cell function is not stimulated by osteocalcin, due to the absence of either the ligand or its receptor, have significantly smaller epididymides and seminal vesicles. Ocndeficient males also have significantly increased levels of serum estradiol, leading to a disturbance in the testosterone:estradiol (T:E) ratio. Estrogens are known to regulate both male fertility and prostate function, and age-dependent changes in the T:E ratio have been implicated in the development of benign and malignant prostate disease. Interestingly, a recent paper has identified GPRC6A as a susceptibility locus for prostate cancer (Takata et al., 2010) . Disturbances in functional activity of bone cells associated with aging may therefore have ramifications not only for male fertility, but also for susceptibility to prostate cancer.
The identification of osteocalcin as a regulator of male fertility represents a step change in our understanding of the homeostatic mechanisms that are responsible for regulation of androgen biosynthesis in the testis. G protein-coupled receptors such as Gprc6A are popular targets for drug development, and these studies may therefore pave the way for treatments for male infertility or other hormone-dependent disorders.
Figure 1. Hormonal Integration of the Skeleton and Testis
Testosterone (T) biosynthesis takes place within Leydig cells (identified here by immunostaining for 3b-HSD, an enzyme that is involved in androgen biosynthesis), located within the interstitial compartment of the testis. Testosterone also acts as a pro-hormone for biosynthesis of estrogens (E); both hormones have been implicated in regulation of bone turnover. Leydig cells express G protein-coupled receptors (GPCRs) that bind the endocrine hormones luteinizing hormone (Lhcgr) and osteocalcin (Gprc6a). Luteinizing hormone (LH) is synthesized and secreted by the pituitary gland and the latter produced by bone osteoblasts. Stimulation of both GPCRs results in increased concentrations of intracellular cAMP and increased expression of key regulators of the steroidogenic pathway. Secretion of LH is subject to negative feedback regulation by testosterone and estrogens. Testosterone, acting via androgen receptors expressed in somatic cells, but not germ cells, plays a critical role in the regulation of male fertility.
